Shixuantang Biopharma Secures Record-Breaking RMB 150 Million Angel Funding, Files IPO Prospectus

Surging Demand in China’s Specialty Hair Care Market: Shixuantang’s Ziping Brand Enters the Arena, Secures RMB 150 Million in Angel FundingThe demand for specialty hair care products in China has surged dramatically, with an annual sales growth rate of 5% and a market size reaching RMB 200 billion. The Ziping brand of hair care products, developed by Shixuantang, has officially entered the market. In 2016, the company established a branch in the United States and formally signed a strategic cooperation agreement to establish the “Sino-US Modern Biological Traditional Chinese Medicine Research Group” in collaboration with experts from the Departments of Neurology and Nuclear Medicine at Washington State University College of Medicine, as well as the Seattle Bio-Cell Laboratory and immunology specialists in the U.S. In July 2016, it opened its first offline experience store in Beijing. Currently, Beijing Shixuantang, leveraging its original proprietary traditional Chinese medicine projects, has secured RMB 150 million in angel funding from Tianhe Rongwang Group. Within six months, its valuation increased tenfold to RMB 1.5 billion, successfully setting a new record for the upper limit of angel financing in China.

Beijing Shixuantang Biological Medicine Technology Co., Ltd. was established in 2003 as a high-tech enterprise located in the Desheng Science and Technology Park of Zhongguancun. The company is dedicated to the research and development of human life sciences and modern biological traditional Chinese medicine (TCM). It possesses multiple original, mature scientific achievements with independent intellectual property rights. Its R&D technologies and products span various fields, including biopharmaceuticals, modern TCM, health foods, and fine chemicals.

The company’s founder, Liu Ziping, graduated from Beijing University of Chinese Medicine in 1979. She is a member of the China Association of Women Entrepreneurs and the China Association of Women Scientists and Technologists, and served as a member of the 10th, 11th, and 12th Committees of the Chinese People’s Political Consultative Conference (CPPCC) for Xicheng District, Beijing. In the early 1980s, Liu Ziping began research and development on fresh plant-based and novel biotechnological approaches to traditional Chinese medicine. She previously served for an extended period as General Manager of the Sino-foreign joint venture Beijing Neichelock Cosmetics Co., Ltd., and as Chief Representative of the Beijing Office of Lia Company (USA). In 1993, her six inventions in bioengineering won six awards at the 42nd Brussels Eureka World Exhibition of Inventions, including four “Special Contribution Gold Medals” and two “Silver Medals.” Her more than 30 years of experience and scientific research accumulation in specialized hair care products have laid a solid foundation for the establishment and development of the enterprise.

Beijing Shixuantang currently possesses a complete industry chain encompassing product R&D, fresh herb cultivation, traditional Chinese medicine extraction, product manufacturing, product sales, and terminal services.The three products launched on the market are: the Hair Growth Series, the Hair Darkening Series, and the Anti-Dandruff Series. The Hair Growth Series utilizes natural biological hair growth agents combined with Expert Liu Ziping’s hair promotion technology to improve scalp blood circulation, promote the regrowth of atrophied primary hair follicles, and stimulate the body’s own secondary hair follicles to develop into new centers for hair growth. The Hair Darkening Series leverages Expert Liu Ziping’s “melanin synthesis technology” to extract fresh nutrients from Eclipta prostrata (Hanlian Cao). Rich in 18 amino acids and five trace elements, this product provides comprehensive organic plant-based nutrients for hair darkening. It contains no photosensitizing or chemically irritating substances, ensuring safer and gentler performance. This series represents a new generation of all-in-one nutritional hair care products that integrate nourishment, cleansing, and conditioning. The Anti-Dandruff Series is extracted from fresh medicinal herbs, offering an organic and healthy formula free from any chemical or pharmaceutical anti-dandruff ingredients. It effectively removes accumulated scalp debris without causing irritation or damage to scalp cells. All three products from Beijing Shixuantang Biological Medicine Technology Co., Ltd. have passed national testing for chemical indicators, microbial indicators, and physicochemical indicators.

Ms. Liu Ziping, Founder and Chairwoman of Beijing Shixuantang, stated, “Traditional Chinese Medicine (TCM) has endured for thousands of years due to its remarkable vitality. To advance, TCM must break free from constraints and embrace innovative thinking, fostering development through innovation while building on its heritage. By leveraging modern high-tech approaches such as bioengineering, TCM should scientifically demonstrate its efficacy through theoretical and clinical evidence, thereby aligning with modern medicine. By integrating traditional TCM theories with modern biotechnology, Shixuantang is committed to providing scientifically grounded, healthy, green, and safe products to all who cherish life and beauty.”

Why Choose Beijing Shixuantang? The head of Shengri Rongwang stated, “The market for specialized hair care products is vast and boasts a considerably long product lifecycle. We believe that the products developed by Ms. Liu Ziping can effectively address the concerns of individuals suffering from hair loss and graying hair. This confidence is grounded in 26 years of clinical trials, data from 4,240 real-world cases, evaluations by 12 authoritative domestic and international industry institutions, and clinical testing conducted at eight prestigious Grade A tertiary hospitals.”

Beijing Tianhe Rongwang Investment Fund Management Co., Ltd. is a wholly-owned subsidiary of Shengri Rongwang Group. Established in 2014 with a registered capital of RMB 100 million, the company’s business scope covers fund issuance and management, equity and debt investments, mergers and acquisitions, and listing planning and operations. Its investment portfolio spans industries such as finance, real estate, energy, environmental protection, biotechnology, and film and media. As of June 2016, the assets under management reached RMB 6 billion.